行情

RKDA

RKDA

阿凯迪亚生物科学
NASDAQ

实时行情|Nasdaq Last Sale

1.260
+0.250
+24.75%
盘后: 1.260 0 0.00% 19:48 05/16 EDT
开盘
1.070
昨收
1.010
最高
1.270
最低
1.070
成交量
419.09万
成交额
0
52周最高
3.250
52周最低
0.7400
市值
2,795.80万
市盈率(TTM)
-1.9379
分时
5日
1月
3月
1年
5年
GOEV, SUNW and APPH among pre market gainers
Rattler Midstream RTLR +14% Diamondback Energy to buy Rattler Midstream in all-stock deal. Spirit Airlines SAVE +14% on new tender offer from JetBlue. AgriFORCE Growing Systems (AGRI) +15%. NanoViricides (NNVC) +14% reports that it has
Seekingalpha · 13小时前
BRIEF-Arcadia Biosciences Announces First Quarter 2022 Financial Results
reuters.com · 4天前
Recap: Arcadia Biosciences Q1 Earnings
Arcadia Biosciences (NASDAQ:RKDA) reported its Q1 earnings results on Thursday, May 12, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
Benzinga · 4天前
Arcadia Biosciences GAAP EPS of -$0.20 beats by $0.14, revenue of $3.22M beats by $1.32M
Arcadia Biosciences press release (NASDAQ:RKDA): Q1 GAAP EPS of -$0.20 beats by $0.14. Revenue of $3.22M (+288.0% Y/Y) beats by $1.32M.
Seekingalpha · 4天前
Arcadia Biosciences Q1 EPS $(0.20) Beats $(0.34) Estimate, Sales $3.22M Beat $1.90M Estimate
Arcadia Biosciences (NASDAQ:RKDA) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(0.34) by 41.18 percent. This is a 281.82 percent decrease over earnings of $0.11 per share
Benzinga · 4天前
-- Earnings Flash (RKDA) ARCADIA BIOSCIENCES Reports Q1 Revenue $3.2M, vs. Street Est of $1.9M
MT Newswires · 4天前
Earnings Reaction History: Arcadia Biosciences Inc, 30.0% Follow-Through Indicator, 12.8% Sensitive
MT Newswires · 4天前
Earnings Preview For Arcadia Biosciences
Arcadia Biosciences (NASDAQ:RKDA) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that Arcadia Biosciences will report an earnings per share (EPS) of...
Benzinga · 5天前
更多
暂无数据
了解RKDA最新的财务预测,通过RKDA每股收益,每股净资产,每股现金流等数据分析阿凯迪亚生物科学近期的经营情况,然后做出明智的投资选择。
分析师评级

2位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

0.00%强力推荐
100.00%买入
0.00%中性
0.00%落后大盘
0.00%卖出
目标价格预测
分析师预测RKDA价格均价为3.750,最高价位4.000,最低价为3.500。
最高4.000
均价3.750
最低3.500
现价1.260
EPS
实际EPS
预期EPS
-0.24-0.14-0.050.05
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Q1 2022
机构持股
总机构数: 36
机构持股: 256.42万
持股比例: 11.56%
总股本: 2,218.89万
类型机构数股数
增持
4
5.14万
建仓
11
77.13万
减持
6
10.38万
平仓
5
154.12万
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
农用化学品
+1.90%
化学品
+0.28%
高管信息
Non-Executive Chairman/Independent Director
Kevin Comcowich
President/Chief Executive Officer
Stanley Jacot
Chief Financial Officer
Pamela Haley
Senior Vice President/Director of Sales
Brian Schaffer
Chief Technology Officer
Randall Shultz
Chief Marketing Officer
Laura Pitlik
Vice President - Operations
Belinda Yao
Independent Director
Albert Bolles
Independent Director
Deborah Carosella
Independent Director
Lilian Shackleford Murray
Independent Director
Gregory Waller
Independent Director
Amy Yoder
暂无数据
暂无数据
RKDA 简况
Arcadia Biosciences Inc从事改良作物研究。该公司研究小麦、大豆和大麻作物,旨在通过改良田间作物的性能以及改良作为工业应用的食品成分、健康和保健产品的价值来发展农场经济。该公司使用育种技术来进行研究。该公司的GoodWheat产品成分有益于消费者健康,并使包装消费品公司能够在市场上脱颖而出。其GoodHemp种子目录提供了大麻种子、移植物和提取物。该公司通过种植红花植物来生产Sonova GLA红花油,该红花植物产生的种子富含γ-亚麻酸(GLA)。该公司还提供Sonova GLA作为成年狗和猫的干狗粮配方的营养添加剂。

微牛提供Arcadia Biosciences Inc(NASDAQ-RKDA)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的RKDA股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易RKDA股票基本功能。